These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6167391

  • 1. Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro.
    Marone G, Kagey-Sobotka A, Lichtenstein LM.
    Clin Immunol Immunopathol; 1981 Aug; 20(2):231-9. PubMed ID: 6167391
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells.
    Choi SH, Sakamoto T, Fukutomi O, Inagaki N, Matsuura N, Nagai H, Koda A.
    J Pharmacobiodyn; 1989 Sep; 12(9):517-22. PubMed ID: 2482349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
    Frye RA, Holz RW.
    Mol Pharmacol; 1983 May; 23(3):547-50. PubMed ID: 6865904
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.
    Henderson LM, Chappell JB, Jones OT.
    Biochem J; 1989 Nov 15; 264(1):249-55. PubMed ID: 2557829
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein.
    Thomas LL, Zheutlin LM, Gleich GJ.
    Immunology; 1989 Apr 15; 66(4):611-5. PubMed ID: 2469646
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of catecholamine release from adrenal chromaffin cells by phospholipase A2- and lipoxygenase-inhibitors.
    Sasakawa N, Yamamoto S, Kumakura K, Kato R.
    Jpn J Pharmacol; 1983 Oct 15; 33(5):1077-80. PubMed ID: 6417385
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of inhibitors of arachidonic acid metabolism upon IgE and non-IgE-mediated histamine release.
    Magro AM.
    Int J Immunopharmacol; 1982 Oct 15; 4(1):15-20. PubMed ID: 6177650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.